Skip to main content
Erschienen in: Sleep and Breathing 4/2023

30.11.2022 | Sleep Breathing Physiology and Disorders • Original Article

The association between biomarker angiopoietin-like protein five and obstructive sleep apnea in patients undergoing bariatric surgery

verfasst von: M. Leentjens, P. F. N. Bosschieter, Abdulmohsen Al-Terki, C. A. L. de Raaff, C. E. E. de Vries, Maha Hammad, Thangavel Alphonse Thanaraj, Irina Al-Khairi, Preethi Cherian, Arshad Channanath, Mohamed Abu-Farha, N. de Vries, Jehad Abubaker

Erschienen in: Sleep and Breathing | Ausgabe 4/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Obstructive sleep apnea (OSA) is prevalent in the bariatric population. OSA should be recognized in patients undergoing bariatric surgery preoperatively to prevent peri- and post-operative complications. Lipid metabolism-related biomarkers are associated with OSA. Triglyceride metabolism is, among others, regulated by angiopoietin-like protein five (ANGPTL5). We aimed to evaluate the level of ANGPTL5 in patients with OSA of different severity levels before and after bariatric surgery.

Methods

We performed a single-center prospective cohort study including a consecutive series of patients who underwent bariatric surgery. We collected the clinical data, polysomnography (PSG) or polygraphy (PG) parameters, and plasma derived via venipuncture before and 6 to 12 months after surgery. Lipid profile, glucose levels, and ANGPTL5 levels were assessed. ANGPTL5 levels were measured using an enzyme-linked immunosorbent assay (ELISA).

Results

The study included 88 patients for analysis. The patients were divided into two subgroups: no or mild OSA (apnea–hypopnea index (AHI) < 15 events/hour, n = 57) and moderate-to-severe OSA (AHI ≥ 15 events/hour, n = 31). The ANGPTL5 level was higher in the moderate-to-severe OSA group (20.5 [15.6, 26.5] ng/mL) compared to the no or mild OSA group (16.3 [12.5, 19.4] ng/mL) (p = 0.008). A significant positive correlation was observed between ANGPTL5 and AHI (ρ = 0.256, p = 0.017), apnea index (AI) (ρ = 0.318, p = 0.003), and triglyceride levels (ρ = 0.240, p = 0.025). ANGPTL5 levels were reduced significantly after bariatric surgery in both moderate-to-severe OSA (15.6 [10.3, 18.7] ng/mL) and no or mild OSA (13.4 [9.2, 15.8] ng/mL) groups, though to a lower level in the group without or mild OSA. Post-surgery, the significant positive correlation between ANGPTL5 and AHI (ρ = 0.210, p = 0.047), AI (ρ = 0.230, p = 0.034), and triglyceride (ρ = 0.397, p < 0.001) remained.

Conclusion

The data showed increased levels of ANGPTL5 in patients with moderate-to-severe OSA. Both AHI and ANGPTL5 levels decreased significantly after bariatric surgery. We also report an association between ANGPTL5 levels and OSA severity.
Literatur
1.
Zurück zum Zitat Lam JC, Mak JC, Ip MS (2012) Obesity, obstructive sleep apnoea and metabolic syndrome. Respirology 17(2):223–236PubMed Lam JC, Mak JC, Ip MS (2012) Obesity, obstructive sleep apnoea and metabolic syndrome. Respirology 17(2):223–236PubMed
2.
Zurück zum Zitat Sanchez-de-la-Torre M, Campos-Rodriguez F, Barbe F (2013) Obstructive sleep apnoea and cardiovascular disease. Lancet Respir Med 1(1):61–72PubMed Sanchez-de-la-Torre M, Campos-Rodriguez F, Barbe F (2013) Obstructive sleep apnoea and cardiovascular disease. Lancet Respir Med 1(1):61–72PubMed
3.
Zurück zum Zitat de Raaff CAL, de Vries N, van Wagensveld BA (n.d) Obstructive sleep apnea and bariatric surgical guidelines: summary and update. (1473–6500 (Electronic)). de Raaff CAL, de Vries N, van Wagensveld BA (n.d) Obstructive sleep apnea and bariatric surgical guidelines: summary and update. (1473–6500 (Electronic)).
5.
Zurück zum Zitat Angrisani L et al (2017) Bariatric surgery and endoluminal procedures: IFSO Worldwide Survey 2014. Obes Surg 27(9):2279–2289PubMedPubMedCentral Angrisani L et al (2017) Bariatric surgery and endoluminal procedures: IFSO Worldwide Survey 2014. Obes Surg 27(9):2279–2289PubMedPubMedCentral
6.
Zurück zum Zitat Angrisani L et al (2021) Bariatric surgery survey 2018: similarities and disparities among the 5 IFSO chapters. Obes Surg 31(5):1937–1948PubMedPubMedCentral Angrisani L et al (2021) Bariatric surgery survey 2018: similarities and disparities among the 5 IFSO chapters. Obes Surg 31(5):1937–1948PubMedPubMedCentral
7.
Zurück zum Zitat Epstein LJ et al (2009) Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med 5(3):263–276PubMed Epstein LJ et al (2009) Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med 5(3):263–276PubMed
8.
Zurück zum Zitat Butt M et al (2010) Obstructive sleep apnea and cardiovascular disease. Int J Cardiol 139(1):7–16PubMed Butt M et al (2010) Obstructive sleep apnea and cardiovascular disease. Int J Cardiol 139(1):7–16PubMed
9.
Zurück zum Zitat Gopalakrishnan P, Tak T (2011) Obstructive sleep apnea and cardiovascular disease. Cardiol Rev 19(6):279–290PubMed Gopalakrishnan P, Tak T (2011) Obstructive sleep apnea and cardiovascular disease. Cardiol Rev 19(6):279–290PubMed
10.
11.
Zurück zum Zitat Kendzerska T et al (2014) Obstructive sleep apnea and incident diabetes. A historical cohort study. Am J Respir Crit Care Med 190(2):218–25PubMed Kendzerska T et al (2014) Obstructive sleep apnea and incident diabetes. A historical cohort study. Am J Respir Crit Care Med 190(2):218–25PubMed
12.
Zurück zum Zitat Godoy J et al (2009) Obstructive sleep apnea as an independent stroke risk factor: possible mechanisms. Curr Mol Med 9(2):203–209PubMed Godoy J et al (2009) Obstructive sleep apnea as an independent stroke risk factor: possible mechanisms. Curr Mol Med 9(2):203–209PubMed
13.
Zurück zum Zitat Ryan S (2017) Adipose tissue inflammation by intermittent hypoxia: mechanistic link between obstructive sleep apnoea and metabolic dysfunction. J Physiol 595(8):2423–2430PubMedPubMedCentral Ryan S (2017) Adipose tissue inflammation by intermittent hypoxia: mechanistic link between obstructive sleep apnoea and metabolic dysfunction. J Physiol 595(8):2423–2430PubMedPubMedCentral
14.
Zurück zum Zitat Passali D et al (2015) Oxidative stress in patients with obstructive sleep apnoea syndrome. Acta Otorhinolaryngol Ital 35(6):420–425PubMedPubMedCentral Passali D et al (2015) Oxidative stress in patients with obstructive sleep apnoea syndrome. Acta Otorhinolaryngol Ital 35(6):420–425PubMedPubMedCentral
15.
Zurück zum Zitat Lin MT et al (2015) Beneficial effect of continuous positive airway pressure on lipid profiles in obstructive sleep apnea: a meta-analysis. Sleep Breath 19(3):809–817PubMed Lin MT et al (2015) Beneficial effect of continuous positive airway pressure on lipid profiles in obstructive sleep apnea: a meta-analysis. Sleep Breath 19(3):809–817PubMed
16.
Zurück zum Zitat Jun JC et al (2012) Acute hypoxia induces hypertriglyceridemia by decreasing plasma triglyceride clearance in mice. Am J Physiol Endocrinol Metab 303(3):E377–E388PubMedPubMedCentral Jun JC et al (2012) Acute hypoxia induces hypertriglyceridemia by decreasing plasma triglyceride clearance in mice. Am J Physiol Endocrinol Metab 303(3):E377–E388PubMedPubMedCentral
17.
Zurück zum Zitat Drager LF et al (2012) Intermittent hypoxia inhibits clearance of triglyceride-rich lipoproteins and inactivates adipose lipoprotein lipase in a mouse model of sleep apnoea. Eur Heart J 33(6):783–790PubMed Drager LF et al (2012) Intermittent hypoxia inhibits clearance of triglyceride-rich lipoproteins and inactivates adipose lipoprotein lipase in a mouse model of sleep apnoea. Eur Heart J 33(6):783–790PubMed
18.
Zurück zum Zitat Yao Q et al (2013) Effect of chronic intermittent hypoxia on triglyceride uptake in different tissues. J Lipid Res 54(4):1058–1065PubMedPubMedCentral Yao Q et al (2013) Effect of chronic intermittent hypoxia on triglyceride uptake in different tissues. J Lipid Res 54(4):1058–1065PubMedPubMedCentral
19.
Zurück zum Zitat Li J et al (2020) Triglyceride metabolism and angiopoietin-like proteins in lipoprotein lipase regulation. Clin Chim Acta 503:19–34PubMed Li J et al (2020) Triglyceride metabolism and angiopoietin-like proteins in lipoprotein lipase regulation. Clin Chim Acta 503:19–34PubMed
20.
Zurück zum Zitat Abu-Farha M et al (2020) The multi-faces of Angptl8 in health and disease: novel functions beyond lipoprotein lipase modulation. Prog Lipid Res 80:101067PubMed Abu-Farha M et al (2020) The multi-faces of Angptl8 in health and disease: novel functions beyond lipoprotein lipase modulation. Prog Lipid Res 80:101067PubMed
21.
Zurück zum Zitat Santulli G (2014) Angiopoietin-like proteins: a comprehensive look. Front Endocrinol 5:4 Santulli G (2014) Angiopoietin-like proteins: a comprehensive look. Front Endocrinol 5:4
23.
Zurück zum Zitat Miida T, Hirayama S (2010) Impacts of angiopoietin-like proteins on lipoprotein metabolism and cardiovascular events. Curr Opin Lipidol 21(1):70PubMed Miida T, Hirayama S (2010) Impacts of angiopoietin-like proteins on lipoprotein metabolism and cardiovascular events. Curr Opin Lipidol 21(1):70PubMed
24.
Zurück zum Zitat Zeng L et al (2003) Identification of a novel human angiopoietin-like gene expressed mainly in heart. 48:159. Zeng L et al (2003) Identification of a novel human angiopoietin-like gene expressed mainly in heart. 48:159.
25.
Zurück zum Zitat Romeo S et al (2009) Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans. J Clin Investig 119(1):70PubMed Romeo S et al (2009) Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans. J Clin Investig 119(1):70PubMed
26.
Zurück zum Zitat Hammad MM et al (2020) Correlation of circulating ANGPTL5 levels with obesity, high sensitivity C-reactive protein and oxidized low-density lipoprotein in adolescents. Sci Rep 10(1):6330PubMedPubMedCentral Hammad MM et al (2020) Correlation of circulating ANGPTL5 levels with obesity, high sensitivity C-reactive protein and oxidized low-density lipoprotein in adolescents. Sci Rep 10(1):6330PubMedPubMedCentral
27.
Zurück zum Zitat Alghanim G et al (2019) Higher levels of ANGPTL5 in the circulation of subjects with obesity and type 2 diabetes are associated with insulin resistance. Front Endocrinol 10:495 Alghanim G et al (2019) Higher levels of ANGPTL5 in the circulation of subjects with obesity and type 2 diabetes are associated with insulin resistance. Front Endocrinol 10:495
29.
Zurück zum Zitat Li C (2007) A tale of two angiopoietin-like proteins. Curr Opin Lipidol 18(5):597PubMed Li C (2007) A tale of two angiopoietin-like proteins. Curr Opin Lipidol 18(5):597PubMed
30.
Zurück zum Zitat Mattijssen F, Kersten S (2012) Regulation of triglyceride metabolism by angiopoietin-like proteins. Biochem Biophys Acta 1821(5):782PubMed Mattijssen F, Kersten S (2012) Regulation of triglyceride metabolism by angiopoietin-like proteins. Biochem Biophys Acta 1821(5):782PubMed
31.
Zurück zum Zitat Kersten S (2005) Regulation of lipid metabolism via angiopoietin-like proteins. Biochem Soc Trans 33(Pt 5):1059PubMed Kersten S (2005) Regulation of lipid metabolism via angiopoietin-like proteins. Biochem Soc Trans 33(Pt 5):1059PubMed
32.
Zurück zum Zitat Haller JF et al (2017) ANGPTL8 requires ANGPTL3 to inhibit lipoprotein lipase and plasma triglyceride clearance. J Lipid Res 58(6):1166–1173PubMedPubMedCentral Haller JF et al (2017) ANGPTL8 requires ANGPTL3 to inhibit lipoprotein lipase and plasma triglyceride clearance. J Lipid Res 58(6):1166–1173PubMedPubMedCentral
33.
Zurück zum Zitat Leth-Espensen KZ et al (2021) The intrinsic instability of the hydrolase domain of lipoprotein lipase facilitates its inactivation by ANGPTL4-catalyzed unfolding. Proc Natl Acad Sci 118(12):e2026650118PubMedPubMedCentral Leth-Espensen KZ et al (2021) The intrinsic instability of the hydrolase domain of lipoprotein lipase facilitates its inactivation by ANGPTL4-catalyzed unfolding. Proc Natl Acad Sci 118(12):e2026650118PubMedPubMedCentral
34.
Zurück zum Zitat Wang Y et al (2013) Mice lacking ANGPTL8 (Betatrophin) manifest disrupted triglyceride metabolism without impaired glucose homeostasis. Proc Natl Acad Sci U S A 110(40):16109–16114PubMedPubMedCentral Wang Y et al (2013) Mice lacking ANGPTL8 (Betatrophin) manifest disrupted triglyceride metabolism without impaired glucose homeostasis. Proc Natl Acad Sci U S A 110(40):16109–16114PubMedPubMedCentral
35.
Zurück zum Zitat Oteng AB et al (2019) Characterization of ANGPTL4 function in macrophages and adipocytes using Angptl4-knockout and Angptl4-hypomorphic mice. J Lipid Res 60(10):1741–1754PubMedPubMedCentral Oteng AB et al (2019) Characterization of ANGPTL4 function in macrophages and adipocytes using Angptl4-knockout and Angptl4-hypomorphic mice. J Lipid Res 60(10):1741–1754PubMedPubMedCentral
36.
Zurück zum Zitat Köster A et al (n.d) Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism. (0013–7227 (Print)). Köster A et al (n.d) Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism. (0013–7227 (Print)).
37.
Zurück zum Zitat Drager LF, Polotsky VY (2011) Lipid metabolism: a new frontier in sleep apnea research. Am J Respir Crit Care Med 184(3):288–290PubMedPubMedCentral Drager LF, Polotsky VY (2011) Lipid metabolism: a new frontier in sleep apnea research. Am J Respir Crit Care Med 184(3):288–290PubMedPubMedCentral
38.
Zurück zum Zitat Savransky V et al (2007) Chronic intermittent hypoxia induces atherosclerosis. Am J Respir Crit Care Med 175(12):1290–1297PubMedPubMedCentral Savransky V et al (2007) Chronic intermittent hypoxia induces atherosclerosis. Am J Respir Crit Care Med 175(12):1290–1297PubMedPubMedCentral
39.
Zurück zum Zitat Al-Terki A et al (2018) Increased level of angiopoietin like proteins 4 and 8 in people with sleep apnea. Front Endocrinol 9:651 Al-Terki A et al (2018) Increased level of angiopoietin like proteins 4 and 8 in people with sleep apnea. Front Endocrinol 9:651
40.
Zurück zum Zitat Li J et al (2020) The clinical role of angiopoietin-like protein 3 in evaluating coronary artery disease in patients with obstructive sleep apnea. Cardiovasc Drugs Ther 34(6):773–780PubMedPubMedCentral Li J et al (2020) The clinical role of angiopoietin-like protein 3 in evaluating coronary artery disease in patients with obstructive sleep apnea. Cardiovasc Drugs Ther 34(6):773–780PubMedPubMedCentral
41.
Zurück zum Zitat Schauer PR et al (2012) Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 366(17):1567–1576PubMedPubMedCentral Schauer PR et al (2012) Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 366(17):1567–1576PubMedPubMedCentral
42.
Zurück zum Zitat Cho J-M et al (2015) Effect of sleeve gastrectomy on type 2 diabetes as an alternative treatment modality to Roux-en-Y gastric bypass: systemic review and meta-analysis. Surg Obes Relat Dis 11(6):1273–1280PubMed Cho J-M et al (2015) Effect of sleeve gastrectomy on type 2 diabetes as an alternative treatment modality to Roux-en-Y gastric bypass: systemic review and meta-analysis. Surg Obes Relat Dis 11(6):1273–1280PubMed
43.
Zurück zum Zitat Singh AK, Singh R, Kota SK (2015) Bariatric surgery and diabetes remission: who would have thought it? Indian J Endocrinol Metab 19(5):563–576PubMedPubMedCentral Singh AK, Singh R, Kota SK (2015) Bariatric surgery and diabetes remission: who would have thought it? Indian J Endocrinol Metab 19(5):563–576PubMedPubMedCentral
44.
Zurück zum Zitat Singh P et al (2020) Impact of bariatric surgery on cardiovascular outcomes and mortality: a population-based cohort study. Br J Surg 107(4):432–442PubMed Singh P et al (2020) Impact of bariatric surgery on cardiovascular outcomes and mortality: a population-based cohort study. Br J Surg 107(4):432–442PubMed
45.
Zurück zum Zitat Marin JM et al (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365(9464):1046–1053PubMed Marin JM et al (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365(9464):1046–1053PubMed
46.
Zurück zum Zitat Ban JJ et al (2014) Regulation of obesity and insulin resistance by hypoxia-inducible factors. Hypoxia (Auckl) 2:171–183PubMed Ban JJ et al (2014) Regulation of obesity and insulin resistance by hypoxia-inducible factors. Hypoxia (Auckl) 2:171–183PubMed
47.
Zurück zum Zitat Bradley TD, Floras JS (2009) Obstructive sleep apnoea and its cardiovascular consequences. Lancet 373(9657):82–93PubMed Bradley TD, Floras JS (2009) Obstructive sleep apnoea and its cardiovascular consequences. Lancet 373(9657):82–93PubMed
Metadaten
Titel
The association between biomarker angiopoietin-like protein five and obstructive sleep apnea in patients undergoing bariatric surgery
verfasst von
M. Leentjens
P. F. N. Bosschieter
Abdulmohsen Al-Terki
C. A. L. de Raaff
C. E. E. de Vries
Maha Hammad
Thangavel Alphonse Thanaraj
Irina Al-Khairi
Preethi Cherian
Arshad Channanath
Mohamed Abu-Farha
N. de Vries
Jehad Abubaker
Publikationsdatum
30.11.2022
Verlag
Springer International Publishing
Erschienen in
Sleep and Breathing / Ausgabe 4/2023
Print ISSN: 1520-9512
Elektronische ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-022-02736-6

Weitere Artikel der Ausgabe 4/2023

Sleep and Breathing 4/2023 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.